Caught in the act: In vivo development of macrolide resistance to Campylobacter jejuni infection

Journal of Clinical Microbiology

Volumn 48, Issue 8, 2010, Pages 3012-3015

  Lindow, J C ^a   Poly, F ^b   Tribble, D R ^b,c   Guerry, P ^b   Carmolli, M P ^a   Baqar, S ^b,e   Porter, C K ^b   Pierce, K K ^a   Darsley, M J ^d,f   Sadigh, K S ^a   Dill, E A ^a   Larsson, Cathy ^a,b,d   Ventrone, Cassandra ^a,b,d   Corrada, Ginger ^a,b,d   Daunais, Patrick ^a,b,d   Lyon, Caroline ^a,b,d   Fingar, Ann ^a,b,d   Gillilan Jr , Theron ^a,b,d   Jones, Erika ^a,b,d   Ewing, Cheryl P ^a,b,d   Dadouk, Sandra ^a,b,d   Sincock, Stephanie ^a,b,d   Lee, Lanfong ^a,b,d   Buchwaldt, Charlotte ^a,b,d   Puel, Pascale ^a,b,d   Miller, Robert ^a,b,d   Matiesen, Dennis ^a,b,d   Kirkpatrick, B D ^a   more..

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b NAVAL MEDICAL RESEARCH CENTER   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d ACE Biosciences   (Denmark)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f TD Vaccines A/S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZITHROMYCIN; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENOMIC DNA; IMIPENEM; LEVOFLOXACIN; TETRACYCLINE; ANTIINFECTIVE AGENT; BACTERIAL DNA; MACROLIDE;

ABDOMINAL CRAMP; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CAMPYLOBACTER JEJUNI; CAMPYLOBACTERIOSIS; COLONY FORMING UNIT; DIARRHEA; EPSILOMETER TEST; EXPERIMENTAL INFECTION; FEVER; HUMAN; HUMAN EXPERIMENT; MALE; MINIMUM INHIBITORY CONCENTRATION; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; VOMITING; BACTERIUM IDENTIFICATION; CAMPYLOBACTER INFECTIONS; CASE REPORT; CLASSIFICATION; DNA FINGERPRINTING; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; YOUNG ADULT;

ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; DNA FINGERPRINTING; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; HUMAN EXPERIMENTATION; HUMANS; MACROLIDES; MALE; MICROBIAL SENSITIVITY TESTS; YOUNG ADULT; HEALTHY VOLUNTEERS;

CAMPYLOBACTER JEJUNI;

EID: 77955452086     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00768-10     Document Type: Article

References (24)

1. Anderson, A. D., J. M. Nelson, S. Rossiter, and F. J. Angulo. 2003. Public health consequences of use of antimicrobial agents in food animals in the United States. Microb. Drug Resist. 9:373-379.
2. Anonymous. 2006. Preliminary FoodNet data on the incidence of infection with pathogens transmitted commonly through food - 10 states, United States, 2005. MMWR Morb. Mortal. Wkly. Rep. 55:392-395.
3. Anonymous. 2007. Preliminary FoodNet data on the incidence of infection with pathogens transmitted commonly through food - 10 states, 2006. MMWR Morb. Mortal. Wkly. Rep. 56:336-339.
4. Baqar, S., D. R. Tribble, M. Carmolli, K. Sadigh, F. Poly, C. Porter, C. J. Larsson, K. K. Pierce, P. Guerry, M. Darsley, and B. Kirkpatrick. 2010. Recrudescent Campylobacter jejuni infection in an immunocompetent adult following experimental infection with a well-characterized organism. Clin. Vaccine Immunol. 17:80-86.
5. Caldwell, D. B., Y. Wang, and J. Lin. 2008. Development, stability, and molecular mechanisms of macrolide resistance in Campylobacter jejuni. Antimicrob. Agents Chemother. 52:3947-3954.
6. CDC. 2009. National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS): human isolates final report, 2007. U.S. Department of Health and Human Services, CDC, Atlanta, GA.
7. Engberg, J., F. M. Aarestrup, D. E. Taylor, P. Gerner-Smidt, and I. Nachamkin. 2001. Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerg. Infect. Dis. 7:24-34.
8. Gibreel, A., V. N. Kos, M. Keelan, C. A. Trieber, S. Levesque, S. Michaud, and D. E. Taylor. 2005. Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype. Antimicrob. Agents Chemother. 49:2753-2759.
9. Gibreel, A., and D. E. Taylor. 2006. Macrolide resistance in Campylobacter jejuni and Campylobacter coli. J. Antimicrob. Chemother. 58:243-255.
10. Guerrant, R. L., T. Van Gilder, T. S. Steiner, N. M. Thielman, L. Slutsker, R. V. Tauxe, T. Hennessy, P. M. Griffin, H. DuPont, R. B. Sack, P. Tarr, M. Neill, I. Nachamkin, L. B. Reller, M. T. Osterholm, M. L. Bennish, and L. K. Pickering. 2001. Practice guidelines for the management of infectious diarrhea. Clin. Infect. Dis. 32:331-351.
11. Han, F., S. Pu, F. Wang, J. Meng, and B. Ge. 2009. Fitness cost of macrolide resistance in Campylobacter jejuni. Int. J. Antimicrob. Agents 34:462-466.
12. Hao, H., M. Dai, Y. Wang, D. Peng, Z. Liu, and Z. Yuan. 2009. 23S rRNA mutation A2074C conferring high-level macrolide resistance and fitness cost in Campylobacter jejuni. Microb. Drug Resist. 15:239-244.
13. Kiehlbauch, J. A., R. A. Albach, L. L. Baum, and K. P. Chang. 1985. Phagocytosis of Campylobacter jejuni and its intracellular survival in mononuclear phagocytes. Infect. Immun. 48:446-451.
14. Kim, J. S., D. K. Carver, and S. Kathariou. 2006. Natural transformation-mediated transfer of erythromycin resistance in Campylobacter coli strains from turkeys and swine. Appl. Environ. Microbiol. 72:1316-1321.
15. Kuschner, R. A., A. F. Trofa, R. J. Thomas, C. W. Hoge, C. Pitarangsi, S. Amato, R. P. Olafson, P. Echeverria, J. C. Sadoff, and D. N. Taylor. 1995. Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent. Clin. Infect. Dis. 21:536-541.
16. Luangtongkum, T., B. Jeon, J. Han, P. Plummer, C. M. Logue, and Q. Zhang. 2009. Antibiotic resistance in Campylobacter: emergence, transmission and persistence. Future Microbiol. 4:189-200.
17. Luo, N., S. Pereira, O. Sahin, J. Lin, S. Huang, L. Michel, and Q. Zhang. 2005. Enhanced in vivo fitness of fluoroquinolone-resistant Campylobacter jejuni in the absence of antibiotic selection pressure. Proc. Natl. Acad. Sci. U. S. A. 102:541-546.
18. Parry, C. M., T. T. Hien, G. Dougan, N. J. White, and J. J. Farrar. 2002. Typhoid fever. N. Engl. J. Med. 347:1770-1782.
19. Poly, F., T. D. Read, Y. H. Chen, M. A. Monteiro, O. Serichantalergs, P. Pootong, L. Bodhidatta, C. J. Mason, D. Rockabrand, S. Baqar, C. K. Porter, D. Tribble, M. Darsley, and P. Guerry. 2008. Characterization of two Campylobacter jejuni strains for use in volunteer experimental infection studies. Infect. Immun. 76:5655-5667.
20. Ruiz-Palacios, G. M. 2007. The health burden of Campylobacter infection and the impact of antimicrobial resistance: playing chicken. Clin. Infect. Dis. 44:701-703.
21. Tribble, D. R., S. Baqar, M. P. Carmolli, C. Porter, K. K. Pierce, K. Sadigh, P. Guerry, C. J. Larsson, D. Rockabrand, C. H. Ventone, F. Poly, C. E. Lyon, S. Dakdouk, A. Fingar, T. Gilliland, P. Daunais, E. Jones, S. Rymarchyk, C. Huston, M. Darsley, and B. D. Kirkpatrick. 2009. Campylobacter jejuni strain CG8421: a refined model for the study of campylobacteriosis and evaluation of Campylobacter vaccines in human subjects. Clin. Infect. Dis. 49:1512-1519.
22. Tribble, D. R., S. Baqar, D. A. Scott, M. L. Oplinger, F. Trespalacios, D. Rollins, R. I. Walker, J. D. Clements, S. Walz, P. Gibbs, E. F. Burg III, A. P. Moran, L. Applebee, and A. L. Bourgeois. 2010. Assessment of the duration of protection in Campylobacter jejuni experimental infection in humans. Infect. Immun. 78:1750-1759.
23. Vacher, S., A. Menard, E. Bernard, and F. Megraud. 2003. PCR-restriction fragment length polymorphism analysis for detection of point mutations associated with macrolide resistance in Campylobacter spp. Antimicrob. Agents Chemother. 47:1125-1128.
24. Vacher, S., A. Menard, E. Bernard, A. Santos, and F. Megraud. 2005. Detection of mutations associated with macrolide resistance in thermophilic Campylobacter spp. by real-time PCR. Microb. Drug Resist. 11:40-47.